MetaCap

China Pharma Insider Trades

NYSE: CPHIHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.4384-0.0655 (-13.00%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

China Pharma insider activity

No China Pharma insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Li Zhilin (CEO & Interim CFO) reporting a transaction in 13,757,063 shares at $0.14 on Sep 29, 2023. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CPHI's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CPHI insider transactions

China Pharma insider transactions
DateInsiderTypeSharesValueFiling
Sep 29, 2023Li ZhilinCEO & Interim CFOAward13,757,063$1.93MForm 4
Sep 9, 2021Li ZhilinCEO & Interim CFOAward1,760,000$1.18MForm 4
Dec 23, 2020Li ZhilinCEO and interim CFOAward2,000,000—Form 4
Apr 28, 2012WAUNG FRANKChief Financial OfficerAward100,000—Form 4
May 25, 2011WAUNG FRANKChief Financial OfficerAward25,000—Form 4
May 25, 2011Li ZhilinPresident and CEOAward50,000—Form 4
Dec 13, 2010WAUNG FRANKChief Financial OfficerAward6,863—Form 4
Nov 15, 2010WAUNG FRANKChief Financial OfficerOption exercise4,052—Form 4
Feb 9, 2010Tsui Heung MeiDirectorAward1,500,000$4.50MForm 4
Nov 26, 2007Tsui Heung MeiDirectorAward4,465,734$6.79MForm 4
Sep 13, 2006Li ZhilinPresident and CEOAward10,000,000—Form 4
Sep 13, 2006Tsui Heung MeiDirectorAward10,000,000—Form 4
May 16, 2006Tsui Heung MeiDirectorAward4,723,056$4.72KForm 4
Oct 4, 2005HALTER TIMOTHY PCEO, Pres, CFO, Chairman & Secother46,875—Form 4
Oct 4, 2005HALTER TIMOTHY PCEO, Pres, CFO, Chairman & SecSale1,828,170$182.82KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related